![](/img/cover-not-exists.png)
825PRandomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) vs. EZ alone in metastatic castration refractory prostate cancer (mCRPC)
Maughan, B L, Hahn, A, Hoffman, J, Morton, K, Gupta, S, Batten, J, Thorley, J, Hawks, J, Nachaegari, G, Nussenzveig, R, Boucher, K, Agarwal, NVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy284.034
Date:
October, 2018
File:
PDF, 90 KB
english, 2018